Sign in
Taking people in United StatesNo phase

Collagen peptide supplement around knee replacement surgery for knee osteoarthritis

Tests a collagen supplement versus placebo in people having knee replacement for osteoarthritis.

Key facts

Who runs it
University of Arkansas
Where
Little Rock, United StatesSee the site
Trial code
Registry title
Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing After Total Knee Arthroplasty (TKA)
Status
Recruiting
People taking part
44 people, planned
Started
1 May 2026
Expected to end
1 Jun 2027
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • SOLUGEL
  • Placebo
Record updated
27 May 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with primary knee osteoarthritis who are scheduled for a total knee replacement (TKA) at UAMS. It tests a collagen peptide supplement against a placebo.

Age
50 to 75 years old
Sex
Men and women. Women must be postmenopausal.
Disease stage
Primary osteoarthritis, with a total knee replacement scheduled at UAMS two months before surgery.
Earlier treatment
No hormone replacement therapy in the last 12 months. No earlier surgery to the ACL in the knee being replaced.
Biomarker or test result
Body mass index of 20.0 to 39.9 kg/m2. COVID-19 negative and/or no symptoms.

Main reasons for not taking part

  • Earlier serious injury to the knee being replaced, or ACL surgery in that knee
  • Women who are not postmenopausal
  • Hormone replacement therapy in the last 12 months
  • Active blood-borne infectious disease
  • Living away from Little Rock or not going to physical therapy in Little Rock

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Males and Females, 50 to 75 years old
  • With a body mass index of 20.0 to 39.9 kg/m2
  • Diagnosed with primary osteoarthritis
  • Scheduled for a TKA at UAMS (two months prior to surgery) at UAMS
  • Live near Little Rock and scheduled to attend physical therapy in Little Rock
  • COVID-19 negative and/or asymptomatic

Who cannot take part

  • Previously sustained serious knee injury or surgery to ACL in TKA knee
  • Having undergone hormone replacement therapy in the last 12 months
  • Active diagnosis of blood borne infectious disease
  • Females not postmenopausal

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 50 and 75 years old?

Where in United States

  • University of Arkansas for Medical SciencesLittle Rock, United StatesContact: Shiloah Kviatkovsky, PhDTaking people

About the trial

What the trial wants to find out

Recruiting will be performed via checking the calendar for scheduled TKA procedures in the > 8 weeks by clinical staff in the UAMS orthopedic clinic. Clinic staff will look for basic inclusion/exclusion criteria in the EMR for those patients. Clinic staff will either contact directly or send contact information to the PI of this study to contact for recruitment purposes. During the initial phone call, study staff will review inclusion/exclusion criteria to verify eligibility and will discuss study specifics and send a link to the current informed consent form located on the UAMS REDCap server. If the subject wishes to enroll, they will do so via electronic consent through REDCap. REDCap will notify study staff that the consent was signed, then study staff will schedule initial baseline study visit.

Read full original descriptionShow less

Visit 1 and Visit 2 will take place at the RIOA at week 0 and week 24, respectively. Participants will report having fasted overnight, and having abstained from alcohol for 24 hours, vigorous exercise for 24 hours, and caffeine for 12 hours. A blood sample will be drawn upon arrival, followed by a DXA scan to measured bone mineral density (BMD) in both hips and lumbar spine, and for body composition, using CTRAL equipment. Participants will also undergo a body water assessment using BIA to determine deuterium dose. Bilateral handgrip strength will be measured via Dynamometer. Participants will fill out a 3-Day food log, physical activity questionnaire, pain scale, KOOS, VR-12, and the POMS. Participants will be given an 8-week supply of their respective treatment supplement, with instructions and a compliance log (to be filled out monthly). Participants will also be given their dose of deuterium oxide (D2O) to be ingested according to instruction at week 2\&3, prior to TKA (week 4).

Tissue samples for ACL, bone fragments, and synovial fluid will be collected by the PI during TKA surgery. All other assessments will be taken during clinical visits with the participant's physical therapists and their orthopedic doctors. The PI will attend some of these visits to assess wound healing, administer handgrip strength assessment, and to replenish participant treatment supply.

The 2 groups in the trial

  • Collagen PeptidesTreatment being tested

    10 grams per day for 24 weeks

    Treatment: SOLUGEL

  • PlaceboPlacebo, for comparison

    10 grams per day maltodextrin for 24 weeks

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing After Total Knee Arthroplasty (TKA)
Plain-language title
Collagen peptide supplement around knee replacement surgery for knee osteoarthritisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT05823727, who can take part
Record updated
27 May 2026